Plasma chitotriosidase enzyme activity as a novel therapeutic monitor for cysteamine treatment in nephropathic cystinosis: A retrospective validation study.

MLA

Veys, Koenraad, et al. “Plasma Chitotriosidase Enzyme Activity as a Novel Therapeutic Monitor for Cysteamine Treatment in Nephropathic Cystinosis: A Retrospective Validation Study.” Molecular Genetics and Metabolism, vol. 142, no. 1, May 2024, p. 108454. EBSCOhost, https://doi.org/10.1016/j.ymgme.2024.108454.

APA

Veys, K., Elmonem, M. A., van den Heuvel, L., Gahl, W. A., & Levtchenko, E. (2024). Plasma chitotriosidase enzyme activity as a novel therapeutic monitor for cysteamine treatment in nephropathic cystinosis: A retrospective validation study. Molecular Genetics and Metabolism, 142(1), 108454. https://doi.org/10.1016/j.ymgme.2024.108454

Chicago

Veys, Koenraad, Mohamed A Elmonem, Lambert van den Heuvel, William A Gahl, and Elena Levtchenko. 2024. “Plasma Chitotriosidase Enzyme Activity as a Novel Therapeutic Monitor for Cysteamine Treatment in Nephropathic Cystinosis: A Retrospective Validation Study.” Molecular Genetics and Metabolism 142 (1): 108454. doi:10.1016/j.ymgme.2024.108454.